Warning! GuruFocus detected
2 Severe warning signs
with N1A.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Navamedic ASA
SIC : 2834
ISIN : NO0010205966
Compare
Compare
Traded in other countries / regions
NAVA.Norway0FDB.UKN1A.GermanyNAVAO.Sweden IPO Date
2019-02-06Description
Navamedic ASA is a pharmaceutical company supplying hospitals and pharmacies with pharmaceutical and medical nutrition products. The company generates its revenue from the Nordic countries.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.45 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.49 | |||||
| Debt-to-EBITDA | 2.55 | |||||
| Interest Coverage | 1.49 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.19 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21.5 | |||||
| 3-Year EBITDA Growth Rate | 55.8 | |||||
| 3-Year EPS without NRI Growth Rate | 24.3 | |||||
| 3-Year Book Growth Rate | 13.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 264.48 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 11.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.89 | |||||
| 9-Day RSI | 24.39 | |||||
| 14-Day RSI | 29.48 | |||||
| 3-1 Month Momentum % | -20.79 | |||||
| 6-1 Month Momentum % | -36.52 | |||||
| 12-1 Month Momentum % | -43.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.42 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.38 | |||||
| Days Inventory | 113.53 | |||||
| Days Sales Outstanding | 40.05 | |||||
| Days Payable | 72.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.6 | |||||
| Shareholder Yield % | 3.83 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.3 | |||||
| Operating Margin % | 5.98 | |||||
| Net Margin % | 0.24 | |||||
| FCF Margin % | 7.06 | |||||
| ROE % | 0.55 | |||||
| ROA % | 0.25 | |||||
| ROIC % | 1.94 | |||||
| 3-Year ROIIC % | 2.68 | |||||
| ROC (Joel Greenblatt) % | 50.55 | |||||
| ROCE % | 9.24 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 244.67 | |||||
| Forward PE Ratio | 25.56 | |||||
| PE Ratio without NRI | 244.67 | |||||
| Price-to-Owner-Earnings | 23.49 | |||||
| PS Ratio | 0.59 | |||||
| PB Ratio | 1.32 | |||||
| Price-to-Free-Cash-Flow | 8.32 | |||||
| Price-to-Operating-Cash-Flow | 8.22 | |||||
| EV-to-EBIT | 11.67 | |||||
| EV-to-EBITDA | 7.98 | |||||
| EV-to-Revenue | 0.69 | |||||
| EV-to-FCF | 10.57 | |||||
| Price-to-GF-Value | 0.34 | |||||
| Price-to-Projected-FCF | 1.38 | |||||
| Price-to-Median-PS-Value | 0.56 | |||||
| Earnings Yield (Greenblatt) % | 8.57 | |||||
| FCF Yield % | 12.28 | |||||
| Forward Rate of Return (Yacktman) % | -10.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Navamedic ASA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 45.898 | ||
| EPS (TTM) (€) | 0.009 | ||
| Beta | -0.02 | ||
| 3-Year Sharpe Ratio | -0.6 | ||
| 3-Year Sortino Ratio | -0.78 | ||
| Volatility % | 28.18 | ||
| 14-Day RSI | 29.48 | ||
| 14-Day ATR (€) | 0.062289 | ||
| 20-Day SMA (€) | 1.79575 | ||
| 12-1 Month Momentum % | -43.87 | ||
| 52-Week Range (€) | 1.49 - 3.09 | ||
| Shares Outstanding (Mil) | 17.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Navamedic ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Navamedic ASA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Navamedic ASA Frequently Asked Questions
What is Navamedic ASA(FRA:N1A)'s stock price today?
The current price of FRA:N1A is €1.49. The 52 week high of FRA:N1A is €3.09 and 52 week low is €1.49.
When is next earnings date of Navamedic ASA(FRA:N1A)?
The next earnings date of Navamedic ASA(FRA:N1A) is .
Does Navamedic ASA(FRA:N1A) pay dividends? If so, how much?
Navamedic ASA(FRA:N1A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers